World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00182273
Date of registration: 13/09/2005
Primary sponsor: Hamilton Health Sciences Corporation
Public title: Canalith Repositioning Procedure for BPPV in Primary Care
Scientific title: Treatment of Benign Paroxysmal Positional Vertigo With the Canalith Repositioning Procedure in Family Practice: A Randomized Controlled Trial
Date of first enrolment: January 2002
Target sample size: 56
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00182273
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment  
Countries of recruitment
Canada
Contacts
Name:   Juan Munoz, MD
Address: 
Telephone:
Email:
Affiliation:  McMaster University
Key inclusion & exclusion criteria

Inclusion Criteria:

- confirmed BPPV by positive Dix-Hallpike test

Exclusion Criteria:

- · Positive results of the Dix-Hallpike maneuver in both right and left head-hanging
position;

- Evidence of ongoing central nervous system disease (e.g., transient ischemic
attack);

- Otitis media;

- Osteosclerosis;

- Inability to tolerate a diagnostic Dix-Hallpike head-hanging maneuver;

- Severe degenerative disc disease of cervical spine;

- Severe and uncontrolled angina or hypertension



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Benign Paroxysmal Positional Vertigo
Intervention(s)
Procedure: Canalith repositioning maneuver (CRM)
Primary Outcome(s)
Self-reported resolution (affirmative response to question: “Do you feel that the dizziness has completely resolved?”) of vertigo and/or a negative result of the Dix-Hallpike maneuver
Secondary Outcome(s)
Duration of cure, relapse rates
Secondary ID(s)
01-24
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history